These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 9173448

  • 1. [Thrombopoietic growth factor--thrombopoietin. Molecular and biological properties].
    Skotnicki AB, Jabłoński MJ.
    Przegl Lek; 1996; 53(11):826-9. PubMed ID: 9173448
    [Abstract] [Full Text] [Related]

  • 2. Thrombopoietin: the primary regulator of megakaryocyte and platelet production.
    Kaushansky K.
    Thromb Haemost; 1995 Jul; 74(1):521-5. PubMed ID: 8578518
    [Abstract] [Full Text] [Related]

  • 3. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
    Murone M, Carpenter DA, de Sauvage FJ.
    Stem Cells; 1998 Jul; 16(1):1-6. PubMed ID: 9474742
    [Abstract] [Full Text] [Related]

  • 4. [Regulation of megakaryopoiesis and thrombopoiesis by thrombopoietin].
    Oda A, Ikeda Y.
    Rinsho Byori; 1998 May; 46(5):430-4. PubMed ID: 9627493
    [Abstract] [Full Text] [Related]

  • 5. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG, Quentmeier H.
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [Abstract] [Full Text] [Related]

  • 6. Thrombopoietin and its receptor.
    Wendling F, Vainchenker W.
    Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170
    [Abstract] [Full Text] [Related]

  • 7. Mpl: from an acute myeloproliferative virus to the isolation of the long sought thrombopoietin.
    Souyri M.
    Semin Hematol; 1998 Jul; 35(3):222-31. PubMed ID: 9685168
    [Abstract] [Full Text] [Related]

  • 8. A possible role for thrombopoietin and its receptor c-mpl in the pathobiology of essential thrombocythemia.
    Griesshammer M, Bangerter M, Schrezenmeier H.
    Semin Thromb Hemost; 1997 Jul; 23(5):419-23. PubMed ID: 9387200
    [Abstract] [Full Text] [Related]

  • 9. c-mpl, the thrombopoietin receptor.
    Vainchenker W, Methia N, Debili N, Titeux M, Wendling F.
    Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
    [Abstract] [Full Text] [Related]

  • 10. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
    Germeshausen M, Schulze H, Gaudig A, Krukemeier S, Strauss G, Welte K, Ballmaier M.
    Klin Padiatr; 2001 Jul; 213(4):155-61. PubMed ID: 11528548
    [Abstract] [Full Text] [Related]

  • 11. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
    Alexander WS, Roberts AW, Maurer AB, Nicola NA, Dunn AR, Metcalf D.
    Stem Cells; 1996 Jul; 14 Suppl 1():124-32. PubMed ID: 11012212
    [Abstract] [Full Text] [Related]

  • 12. The structure, biology and potential therapeutic applications of recombinant thrombopoietin.
    Lok S, Foster DC.
    Stem Cells; 1994 Nov; 12(6):586-98. PubMed ID: 7881359
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S, Kimura T, Sakabe H, Ohmizono Y, Kato T, Miyazaki H, Yamagishi H, Sonoda Y.
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [Abstract] [Full Text] [Related]

  • 14. Thrombopoietin: biology and clinical potentials.
    Miyazaki H, Kato T.
    Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
    [Abstract] [Full Text] [Related]

  • 15. The role of the MPL receptor in myeloproliferative disorders.
    Kaushansky K.
    Leukemia; 1998 Sep; 12 Suppl 1():S47-50. PubMed ID: 9777896
    [Abstract] [Full Text] [Related]

  • 16. [Biology of thrombopoietin and its receptors].
    Robak T.
    Postepy Hig Med Dosw; 1996 Sep; 50(6):649-63. PubMed ID: 9064684
    [Abstract] [Full Text] [Related]

  • 17. Megakaryocyte development and platelet production.
    Deutsch VR, Tomer A.
    Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888
    [Abstract] [Full Text] [Related]

  • 18. Tec protein-tyrosine kinase is involved in the thrombopoietin/c-Mpl signaling pathway.
    Yamashita Y, Miyazato A, Shimizu R, Komatsu N, Miura Y, Ozawa K, Mano H.
    Exp Hematol; 1997 Mar; 25(3):211-6. PubMed ID: 9091296
    [Abstract] [Full Text] [Related]

  • 19. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production.
    Kaushansky K, Drachman JG.
    Oncogene; 2002 May 13; 21(21):3359-67. PubMed ID: 12032774
    [Abstract] [Full Text] [Related]

  • 20. Thrombopoietin in vitro and in vivo.
    Alexander WS, Begley CG.
    Cytokines Cell Mol Ther; 1998 Mar 13; 4(1):25-34. PubMed ID: 9557214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.